George K. Ng
CEO & DirectorMr. George K. Ng, Esq. JD, serves as CEO of Processa Pharmaceuticals, Inc. since August 08, 2023 and serves as its Director since August 08, 2023 and served as its Director since August 08 2023 until 2024. He is the Co-Founder of Iacta Pharmaceuticals, Inc. serves as its Chief Business Officer since January 2020 and serves as its Director. He is a Partner at PENG Life Science Ventures since September 2013. He has been Independent Director of TuHURA Biosciences, Inc. (formerly, Morphogenesis, Inc.) since October 18, 2024. He served as President and Chief Operations Officer at Calidi Biotherapeutics, Inc. since October 2019 until June 23, 2023 and served as its Board Member since October 2019 until September 20, 2024. Mr. Ng was the Chief Administrative Officer, Executive Vice President and Chief Legal Officer of Sorrento Therapeutics, Inc. since March 30, 2015 until 2018 and served as its Corporate Secretary until April 1, 2019. He served as Senior Vice President and General Counsel of BioDelivery Sciences International, Inc. from December 2012 to 2015. He has more than a decade of experience in both law and the pharmaceutical and life sciences fields. Mr. Ng previously served as a Director of Inflammatory Response Research, Incorporated from May2019 to April 2020, as a Director of Invent Medical Corporation from July 2019 to January 2020, as a Director of ImmuneOncia Therapeutics Incorporated from June 2016 to 2019 and as a Director of Virttu Biologics Limited from April 2017 to April 2019. He was the Co-Founder and President, Business of Scilex Pharmaceuticals Incorporated from September 2012 to April 2019. Mr. Ng has held various senior management positions with publicly-traded, global biotechnology and pharmaceutical companies, including Spectrum Pharmaceuticals, Inc. and Alpharma, Inc. with oversight over legal, intellectual property, litigation and compliance matters. From 2007 to 2010, Mr. Ng served in numerous legal, compliance, IP and management roles with Spectrum Pharmaceuticals, Inc. ultimately as the Head of Legal, Chief Compliance Officer & Chief IP Counsel. He has been responsible for the legal lead in due diligence, negotiations and contract preparation for multiple business development transactions, including U.S. and ex-U.S. licenses, global collaboration agreements and intellectual property and product acquisitions. He has contributed his expertise to the launches and commercialization efforts of multiple pharmaceutical drug products, co-founding and leading one pain medication company from preclinical to clinical research, through NDA submission, FDA approval, commercialization and the subsequent sale of the business—raising in non-dilutive commercialization funding in the process. From 2010 to 2012, Mr. Ng was a Partner in two AMLAW 200 law firms where he held leadership roles, including establishing the life sciences practice group for one firm and Heading it as the national co-Chair. In his private practice positions, Mr. Ng's responsibilities included patent and trademark prosecution, licensing and litigation support, with areas of expertise including drug delivery technologies and medical devices. In 2012, he was a recipient of M&A Advisor's Top 40 Under 40 Award. In 2010, MDB Capital recognized him for its Best and Brightest Award and as an Astrum Award for a pharmaceutical patent portfolio that he developed and managed. Mr. Ng earned a Juris Doctor (J.D.) degree in law from the University of Notre Dame School of Law and a Bachelor of Arts and Sciences (B.A.S.) dual degree in Biochemistry & Economics from the University of California, Davis.
Positions
- Company NameProcessa Pharmaceuticals, Inc.Stock CodePCSAPositionCEO & DirectorColleagues
- SKSheila K. GujrathiExecutive Chair of the Board
- RLRussell L. SkibstedChief Financial Officer
- DYDavid YoungCo-Founder, President of Research and Development & Director
- PLPatrick LinCo-Founder, Chief Business & Strategy Officer
- JWJustin W. YorkeIndependent Director
- GLGeraldine Liu PannuIndependent Director
- Company NameTuHURA Biosciences, Inc.Stock CodeHURAPositionIndependent DirectorColleagues
- JAJames A. BiancoPresident, CEO & Director
- JSJames S. J. ManusoIndependent Chairman of the Board
- DDDan DearbornExecutive VP of Finance & CFO
- MLMichael LawmanCo-Founder
- PLPatricia LawmanCo-Founder
- MKMichael KrsulichHead of Quality Assurance
- GKGeorge K. NgIndependent Director
- AFAlan F. ListIndependent Director
- RERobert E. HoffmanDirector
